Is HPE’s (HPE) Private AI Push in Healthcare and Telecom Reframing Its Enterprise Edge Strategy?

هيوليت باكارد +2.63%

Hewlett Packard Enterprise Co.

HPE

24.61

+2.63%

  • In late January 2026, Iterate.ai and TD SYNNEX launched Generate for Healthcare, an AI-powered claims recovery solution running on HPE Private Cloud AI and HPE ProLiant DL380a Gen12 servers, while HPE also announced a private AI platform collaboration with New Zealand telecom operator 2degrees.
  • Together, these moves highlight how HPE is embedding its AI infrastructure into high-value healthcare and telecom workflows, tying its technology directly to customer revenue recovery, network reliability, and data-sovereign digital transformation.
  • Next, we’ll examine how HPE’s focus on private cloud AI for regulated sectors shapes its investment narrative amid growing enterprise AI adoption.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 33 best rare earth metal stocks of the very few that mine this essential strategic resource.

What Is Hewlett Packard Enterprise's Investment Narrative?

To own Hewlett Packard Enterprise, you have to believe in a steady, infrastructure-led AI story rather than a high-growth software one. The core thesis still leans on HPE GreenLake, networking and storage to pull the company back to consistent profitability while maintaining capital returns, all at a valuation that remains below many tech peers on sales multiples and analyst fair value estimates. The new Iterate.ai / TD SYNNEX healthcare offering and the 2degrees private AI platform do not suddenly transform the near-term financial picture, but they do reinforce one of the clearest current catalysts: HPE’s push to make Private Cloud AI the default choice for regulated, high-value workloads. At the same time, the company is still working through weak earnings coverage of its dividend, limited cash flow flexibility and a need to prove that AI wins can scale meaningfully.

However, one risk many investors might overlook is how thin current cash flows are against HPE’s commitments. Hewlett Packard Enterprise's shares have been on the rise but are still potentially undervalued by 31%. Find out what it's worth.

Exploring Other Perspectives

HPE 1-Year Stock Price Chart
HPE 1-Year Stock Price Chart
Five Simply Wall St Community fair value views span roughly US$17.90 to US$33.64, underlining how differently people price HPE’s AI and cloud pivot. Set that against the still-fragile earnings profile and dividend coverage, and it is clear why many investors may want to compare several viewpoints before deciding how much of HPE’s AI progress they are willing to pay for.

Explore 5 other fair value estimates on Hewlett Packard Enterprise - why the stock might be worth as much as 45% more than the current price!

Build Your Own Hewlett Packard Enterprise Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Hewlett Packard Enterprise research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
  • Our free Hewlett Packard Enterprise research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Hewlett Packard Enterprise's overall financial health at a glance.

Contemplating Other Strategies?

Our top stock finds are flying under the radar-for now. Get in early:

  • Outshine the giants: these 27 early-stage AI stocks could fund your retirement.
  • AI is about to change healthcare. These 107 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.